Tekmira Pharma (TKMR) Study Shows Efficacy Against the Marburg Hemorrhagic Fever Virus
Go back to Tekmira Pharma (TKMR) Study Shows Efficacy Against the Marburg Hemorrhagic Fever VirusTEKMIRA PHARM (NASDAQ: TKMR) | Delayed: 10.83 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $10.83 | 52 Week High | $29.93 | |||
Open | $0.00 | 52 Week Low | $10.02 | |||
Day High | $10.83 | P/E | N/A | |||
Day Low | $10.83 | EPS | $0.00 | |||
Volume | 556,335 |